Burning Rock Biotech (BNR) EBIAT (2020 - 2025)
Historic EBIAT for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$2.4 million.
- Burning Rock Biotech's EBIAT rose 5377.82% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.7 million, marking a year-over-year increase of 7198.71%. This contributed to the annual value of -$47.5 million for FY2024, which is 4842.02% up from last year.
- Latest data reveals that Burning Rock Biotech reported EBIAT of -$2.4 million as of Q3 2025, which was up 5377.82% from -$1.4 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's EBIAT registered a high of -$1.4 million during Q2 2025, and its lowest value of -$41.2 million during Q1 2022.
- Its 5-year average for EBIAT is -$21.7 million, with a median of -$24.0 million in 2023.
- Per our database at Business Quant, Burning Rock Biotech's EBIAT crashed by 21366.21% in 2021 and then soared by 9089.2% in 2025.
- Quarter analysis of 5 years shows Burning Rock Biotech's EBIAT stood at -$39.4 million in 2021, then rose by 20.45% to -$31.4 million in 2022, then increased by 27.12% to -$22.8 million in 2023, then soared by 51.26% to -$11.1 million in 2024, then soared by 78.85% to -$2.4 million in 2025.
- Its EBIAT stands at -$2.4 million for Q3 2025, versus -$1.4 million for Q2 2025 and -$1.9 million for Q1 2025.